Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 15:375:578031.
doi: 10.1016/j.jneuroim.2023.578031. Epub 2023 Jan 21.

Genome-wide identification of murine interferon genes in microglial-mediated neuroinflammation in Alzheimer's disease

Daniel C Shippy  1 , Tyler K Ulland  2
Affiliations

Genome-wide identification of murine interferon genes in microglial-mediated neuroinflammation in Alzheimer's disease

Daniel C Shippy et al. J Neuroimmunol. .

Abstract

Interferons play a major role in microglial-mediated neuroinflammation in Alzheimer's disease (AD). We investigated the interferon transcriptome (AD versus non-AD) using N9 and murine microglia. We identified 64 interferon-related differentially expressed genes (DEG) in LPS-stimulated N9 microglia versus control cells, 26 DEG in microglia from 5XFAD versus wild-type mice, with 13 DEG common to both datasets. Network analyses identified potential key mediators (Cxcl10, Ifit3) of the interferon response in AD. Gene-drug interaction analysis identified therapeutics targeting interferon-related genes. These data characterize the microglial interferon response in AD, providing new targets and therapeutics directed towards interferon-related neuroinflammation in AD.

Keywords: Alzheimer's disease; Interferon; Microglia; Neuroinflammation; Transcriptomics.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Figure 1.
Figure 1.. Differentially expressed murine microglial interferon genes in AD.
(A) Scatter plot of interferon DEG (log2FC > 0.5, FDR-adjusted P-value < 0.05) by RNA-seq in N9 microglia stimulated with LPS (1 μg/ml) for 6 hours versus unstimulated control cells. (B) Scatter plot of interferon DEG (log2FC > 0.5, P < 0.05) by microarray in microglia isolated from the brains of 5XFAD mice versus wild-type mice (8 months old). For both scatter plots, up-regulated genes are shown in red and down-regulated genes are shown in green. (C) Venn diagram displaying overlap in interferon DEG between the datasets.
Figure 2.
Figure 2.. Gene Ontology Biological Process enrichment analysis.
Biological process (BP) analysis of the N9 (A) and mouse (B) microglial interferon DEG was performed using DAVID. Gene Ontology (GO) BP terms with a gene count ≥ 4 and FDR < 0.05 were considered significant. Selected GO BP terms are shown with a complete list available in supplementary tables S3 and S4.
Figure 3.
Figure 3.. Ifit3 expression network analyses.
Analyses for Ifit3 positively correlated genes (A) and predicted regulators (B). The gene constellations shown were generated in ImmGen using the “myeloid cells” reference populations option. The predicted regulators were identified using ImmGens Predicted Interferons Network tool. The vertical green line indicates the confidence threshold at 1% FDR.
Figure 4.
Figure 4.. Cxcl10 expression network analyses.
Analyses for Cxcl10 positively correlated genes (A) and predicted regulators (B). Genes constellations and predicted regulators were generated using the same tools as used for Ifit3 (Figure 3).
Figure 5.
Figure 5.. Gene-drug interactions.
Interactions between therapeutic drugs and the N9 (A) and mouse (B) microglial interferon DEG. Genes identified with drug interactions are shown and the number of drugs associated with each gene is shown above each bar. (C) Experimental validation of selected drugs targeting Cxcl10. N9 microglia were treated with methylprednisolone, zidovudine, and DMSO (control) and stimulated with LPS (1 μg/ml) for 6 hours. Supernatants were collected and assayed for CXCL10 by ELISA. (D) Drug toxicity in N9 microglia treated with methylprednisolone, zidovudine, and DMSO (control) for 8 hours. Cytotoxicity was determined by LDH release in the cell culture supernatants. Data are shown as mean ± SEM. ***P < 0.001, **P < 0.01. ns = not significant.
Figure 6.
Figure 6.. Interferon-related cytokines and chemokines induced by LPS in microglia.
Primary microglia were stimulated with LPS (50 ng/ml) for 6 hours. N9 microglia were stimulated with LPS (1 μg/ml) for 6 hours. Supernatants were collected and assayed for CXCL10 secreted by primary (A) and N9 (B) microglia. Supernatants were also assay for IFN-β secreted by primary (C) and N9 (D) microglia. Experiments were performed in duplicate. Results are from three independent experiments. Data are shown as mean ± SEM. ****P ≤ 0.0001. IFN-α was also evaluated, but was below the detection limit of the assay.
See this image and copyright information in PMC

References

    1. Baik SH, Kang S, Son SM and Mook-Jung I, 2016. Microglia contributes to plaque growth by cell death due to uptake of amyloid beta in the brain of Alzheimer’s disease mouse model. Glia 64, 2274–2290. - PubMed
    1. Bate C, Kempster S, Last V and Williams A, 2006. Interferon-gamma increases neuronal death in response to amyloid-beta1–42. J Neuroinflammation 3, 7. - PMC - PubMed
    1. Belkhelfa M, Rafa H, Medjeber O, Arroul-Lammali A, Behairi N, Abada-Bendib M, Makrelouf M, Belarbi S, Masmoudi AN, Tazir M and Touil-Boukoffa C, 2014. IFN-gamma and TNF-alpha are involved during Alzheimer disease progression and correlate with nitric oxide production: a study in Algerian patients. J Interferon Cytokine Res 34, 839–47. - PubMed
    1. Bradburn S, McPhee J, Bagley L, Carroll M, Slevin M, Al-Shanti N, Barnouin Y, Hogrel JY, Paasuke M, Gapeyeva H, Maier A, Sipila S, Narici M, Robinson A, Mann D, Payton A, Pendleton N, Butler-Browne G and Murgatroyd C, 2018. Dysregulation of C-X-C motif ligand 10 during aging and association with cognitive performance. Neurobiol Aging 63, 54–64. - PMC - PubMed
    1. Chakrabarty P, Ceballos-Diaz C, Beccard A, Janus C, Dickson D, Golde TE and Das P, 2010. IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice. J Immunol 184, 5333–43. - PMC - PubMed

Publication types